centogene
information
security
management
system
awarded
iso
iec
accreditation
company
awarded
iso
accreditation
information
security
management
system
internationally
recognized
certification
set
international
organization
standardization
iso
partnership
international
electrotechnical
commission
iec
accreditation
demonstrates
company
information
security
management
system
successful
adherence
highest
standards
cambridge
mass
rostock
germany
berlin
globe
newswire
centogene
nasdaq
cntg
company
focused
rare
diseases
transforms
clinical
genetic
data
actionable
information
patients
physicians
pharmaceutical
companies
today
announced
company
awarded
iso
iec
certification
following
extensive
audit
information
security
management
system
accreditation
based
standards
set
international
organization
standardization
iso
partnership
international
electrotechnical
commission
iec
certification
verifies
company
processes
systems
support
highest
level
confidentiality
availability
integrity
processed
data
patient
data
employee
data
customer
data
business
partner
data
etc
arndt
rolfs
ceo
centogene
said
responsibility
implement
stringent
technology
infrastructures
provides
secure
data
measures
peace
mind
work
accreditation
another
milestone
company
validates
commitment
quality
security
centogene
proud
received
authorization
recognizes
continued
efforts
meeting
highest
quality
standards
added
volkmar
weckesser
centogene
chief
information
officer
secure
processes
especially
vital
biotechnology
field
proud
services
offer
patients
partners
milestone
underlines
importance
adhering
strictest
quality
criteria
field
meet
diagnostic
clinical
trial
research
development
centogene
centogene
engages
diagnosis
research
around
rare
diseases
transforming
clinical
genetic
data
actionable
information
patients
physicians
pharmaceutical
companies
goal
bring
rationality
treatment
decisions
accelerate
development
new
orphan
drugs
using
extensive
rare
disease
knowledge
including
epidemiological
clinical
data
well
innovative
biomarkers
centogene
developed
global
proprietary
rare
disease
platform
based
data
repository
billion
weighted
data
points
approximately
patients
representing
different
countries
august
company
platform
includes
epidemiologic
phenotypic
genetic
data
reflects
global
population
also
biobank
patients
blood
samples
centogene
believes
represents
platform
comprehensively
analyzes
data
improve
understanding
rare
hereditary
diseases
aid
identification
patients
improve
pharmaceutical
partners
ability
bring
orphan
drugs
market
august
company
collaborated
pharmaceutical
partners
covering
different
rare
diseases
important
notice
disclaimer
press
release
contains
statements
constitute
forward
looking
statements
term
defined
united
states
private
securities
litigation
reform
act
including
statements
express
company
opinions
expectations
beliefs
plans
objectives
assumptions
projections
regarding
future
events
future
results
contrast
statements
reflect
historical
facts
examples
include
discussion
strategies
financing
plans
growth
opportunities
market
growth
cases
identify
statements
terminology
anticipate
intend
believe
estimate
plan
seek
project
expect
may
would
could
negative
terms
similar
expressions
forward
looking
statements
based
management
current
beliefs
assumptions
information
currently
available
company
however
statements
guarantee
performance
place
undue
reliance
statements
statements
subject
many
risks
uncertainties
variable
circumstances
negative
worldwide
economic
conditions
ongoing
instability
volatility
worldwide
financial
markets
effects
pandemic
business
results
operations
possible
changes
current
proposed
legislation
regulations
policies
pressures
increasing
competition
consolidation
industry
expense
uncertainty
regulatory
approval
including
food
drug
administration
reliance
third
parties
collaboration
partners
including
ability
manage
growth
enter
new
client
relationships
dependency
rare
disease
industry
ability
manage
international
expansion
reliance
key
personnel
reliance
intellectual
property
protection
fluctuations
operating
results
due
effect
exchange
rates
factors
risks
uncertainties
may
cause
statements
inaccurate
readers
cautioned
place
undue
reliance
statements
many
risks
outside
company
control
could
cause
actual
results
differ
materially
thought
would
occur
statements
included
press
release
made
date
hereof
company
undertake
specifically
declines
obligation
update
statements
publicly
announce
results
revisions
statements
reflect
future
events
developments
except
required
law
information
please
refer
risk
factors
section
annual
report
year
ended
december
form
filed
sec
april
form
containing
financial
results
three
months
ended
march
filed
sec
june
current
reports
documents
filed
securities
exchange
commission
sec
may
get
documents
visiting
edgar
sec
website
media
contact
centogene
ben
legg
corporate
communications
fti
consulting
bridie
lawlor
